Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Involvement of leptin in the progression of experimentally induced peritoneal fibrosis in mice.

Nakazawa M, Obata Y, Nishino T, Abe S, Nakazawa Y, Abe K, Furusu A, Miyazaki M, Koji T, Kohno S.

Acta Histochem Cytochem. 2013 Apr 30;46(2):75-84. doi: 10.1267/ahc.13005. Epub 2013 Apr 12.

2.

TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model.

Yoshio Y, Miyazaki M, Abe K, Nishino T, Furusu A, Mizuta Y, Harada T, Ozono Y, Koji T, Kohno S.

Kidney Int. 2004 Oct;66(4):1677-85.

3.

Involvement of lymphocyte infiltration in the progression of mouse peritoneal fibrosis model.

Nishino T, Ashida R, Obata Y, Furusu A, Abe K, Miyazaki M, Koji T, Kohno S.

Ren Fail. 2012;34(6):760-6. doi: 10.3109/0886022X.2012.676527. Epub 2012 Apr 17.

PMID:
22506622
4.

Antisense oligonucleotides against collagen-binding stress protein HSP47 suppress peritoneal fibrosis in rats.

Nishino T, Miyazaki M, Abe K, Furusu A, Mishima Y, Harada T, Ozono Y, Koji T, Kohno S.

Kidney Int. 2003 Sep;64(3):887-96.

5.

SAHA Suppresses Peritoneal Fibrosis in Mice.

Io K, Nishino T, Obata Y, Kitamura M, Koji T, Kohno S.

Perit Dial Int. 2015 May-Jun;35(3):246-58. doi: 10.3747/pdi.2013.00089. Epub 2014 Mar 1.

PMID:
24584598
6.

Tissue factor and factor v involvement in rat peritoneal fibrosis.

Saito H, Kitamoto M, Kato K, Liu N, Kitamura H, Uemura K, Nogaki F, Takeda T, Mori N, Ono T.

Perit Dial Int. 2009 May-Jun;29(3):340-51.

PMID:
19458308
7.

22-Oxacalcitriol prevents progression of peritoneal fibrosis in a mouse model.

Hirose M, Nishino T, Obata Y, Nakazawa M, Nakazawa Y, Furusu A, Abe K, Miyazaki M, Koji T, Kohno S.

Perit Dial Int. 2013 Mar-Apr;33(2):132-42. doi: 10.3747/pdi.2011.00234. Epub 2012 Oct 2.

8.

Peritoneal fibrosis and high transport are induced in mildly pre-injured peritoneum by 3,4-dideoxyglucosone-3-ene in mice.

Yokoi H, Kasahara M, Mori K, Kuwabara T, Toda N, Yamada R, Namoto S, Yamamoto T, Seki N, Souma N, Yamaguchi T, Sugawara A, Mukoyama M, Nakao K.

Perit Dial Int. 2013 Mar-Apr;33(2):143-54. doi: 10.3747/pdi.2011.00033. Epub 2012 Nov 1.

9.

Thalidomide prevents the progression of peritoneal fibrosis in mice.

Arai H, Furusu A, Nishino T, Obata Y, Nakazawa Y, Nakazawa M, Hirose M, Abe K, Koji T, Kohno S.

Acta Histochem Cytochem. 2011 Apr 28;44(2):51-60. doi: 10.1267/ahc.10030. Epub 2011 Apr 21.

10.
11.

Pleiotrophin triggers inflammation and increased peritoneal permeability leading to peritoneal fibrosis.

Yokoi H, Kasahara M, Mori K, Ogawa Y, Kuwabara T, Imamaki H, Kawanishi T, Koga K, Ishii A, Kato Y, Mori KP, Toda N, Ohno S, Muramatsu H, Muramatsu T, Sugawara A, Mukoyama M, Nakao K.

Kidney Int. 2012 Jan;81(2):160-9. doi: 10.1038/ki.2011.305. Epub 2011 Aug 31.

12.

Increased susceptibility to oxidant-mediated tissue injury and peritoneal fibrosis in acatalasemic mice.

Fukuoka N, Sugiyama H, Inoue T, Kikumoto Y, Takiue K, Morinaga H, Nakao K, Maeshima Y, Asanuma M, Wang DH, Ogino K, Masuoka N, Makino H.

Am J Nephrol. 2008;28(4):661-8. doi: 10.1159/000121357. Epub 2008 Mar 13.

PMID:
18337633
13.

Inhibition of EGF Receptor Blocks the Development and Progression of Peritoneal Fibrosis.

Wang L, Liu N, Xiong C, Xu L, Shi Y, Qiu A, Zang X, Mao H, Zhuang S.

J Am Soc Nephrol. 2016 Sep;27(9):2631-44. doi: 10.1681/ASN.2015030299. Epub 2015 Dec 17.

PMID:
26677863
14.

Enhanced expression of heat shock protein 47 in rat model of peritoneal fibrosis.

Mishima Y, Miyazaki M, Abe K, Ozono Y, Shioshita K, Xia Z, Harada T, Taguchi T, Koji T, Kohno S.

Perit Dial Int. 2003 Jan-Feb;23(1):14-22.

PMID:
12691502
15.

Epigallocatechin gallate suppresses peritoneal fibrosis in mice.

Kitamura M, Nishino T, Obata Y, Furusu A, Hishikawa Y, Koji T, Kohno S.

Chem Biol Interact. 2012 Jan 5;195(1):95-104. doi: 10.1016/j.cbi.2011.11.002. Epub 2011 Nov 15.

PMID:
22101032
16.

The effects of colchicine on the progression and regression of encapsulating peritoneal sclerosis.

Bozkurt D, Bicak S, Sipahi S, Taskin H, Hur E, Ertilav M, Sen S, Duman S.

Perit Dial Int. 2008 Nov;28 Suppl 5:S53-7. Erratum in: Perit Dial Int. 2009 Mar-Apr;29(2):131-2.

PMID:
19008543
17.

Effects of liposome-encapsulated clodronate on chlorhexidine gluconate-induced peritoneal fibrosis in rats.

Kushiyama T, Oda T, Yamada M, Higashi K, Yamamoto K, Oshima N, Sakurai Y, Miura S, Kumagai H.

Nephrol Dial Transplant. 2011 Oct;26(10):3143-54. doi: 10.1093/ndt/gfr068. Epub 2011 Mar 1.

PMID:
21362737
18.

Inhibitory effects of matrix metalloproteinase inhibitor ONO-4817 on morphological alterations in chlorhexidine gluconate-induced peritoneal sclerosis rats.

Ro Y, Hamada C, Inaba M, Io H, Kaneko K, Tomino Y.

Nephrol Dial Transplant. 2007 Oct;22(10):2838-48. Epub 2007 Jun 2.

PMID:
17545675
19.

Development of a peritoneal sclerosis rat model using a continuous-infusion pump.

Komatsu H, Uchiyama K, Tsuchida M, Isoyama N, Matsumura M, Hara T, Fukuda M, Kanaoka Y, Naito K.

Perit Dial Int. 2008 Nov-Dec;28(6):641-7.

PMID:
18981396
20.

Supplemental Content

Support Center